Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
Go back to Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.23 +0.01 (0.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.22 | 52 Week High | $45.34 | |||
| Open | $3.25 | 52 Week Low | $15.92 | |||
| Day High | $3.25 | P/E | 1.39 | |||
| Day Low | $3.13 | EPS | $2.33 | |||
| Volume | 1,162,684 | |||||
